http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 09 Jan 2025 08:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34 http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html <p> PALO ALTO, Calif.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;esheet=54175714&amp;newsitemid=20250109478180&amp;lan=en-US&amp;anchor=Frazier+Life+Sciences&amp;index=1&amp;md5=b7631d1ec244bd8275e694eead1818f2" shape="rect">Frazier Life Sciences</a> (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointments of Mitchell H. Gold, M.D., and Stanford L. Peng, M.D., Ph.D., as Venture Partners. </p><p> "We believe Mitch and Stanford bring exceptional leadership and experience that will elevate our ability to create and nurture breakthrough biopharmaceutical companies,” said Jamie Topper, M.D., Ph.D., Managing Partner at FLS. “Mitch's history of building transformative companies, his relentless pursuit of scientific excellence and his proven ability to identify transformative scientific and investment opportunities make him a valuable addition to http://www.streetinsider.com/Business+Wire/Frazier+Life+Sciences+Appoints+Biotech+Innovators+Mitchell+H.+Gold+and+Stanford+L.+Peng+as+Venture+Partners/24189140.html Thu, 09 Jan 2025 08:00:00 -0500 A.00641573 A.03607790 A.11515172 A.11608963 A.12042014 A.23553406 A.33644901 A.41351696 A.50114019 ALPN O.00644488 O.00675406 O.01899048 O.02027210 O.04149547 O.05232554 O.20147506 O.48420453 O.48432974 S1GE34